Akagera Medicines is currently planning to initiate a Phase I trial for its lead tuberculosis therapeutic in Q1 of 2024…
Click here to view original post
Akagera Medicines is currently planning to initiate a Phase I trial for its lead tuberculosis therapeutic in Q1 of 2024…
Click here to view original post
Copyright © 2023 Biotech Networks, LLC